October's 10 most-bought funds
4th November 2014 16:05
by Rebecca Jones from interactive investor
Share on
Neil Woodford's flagship fund
remains the most-bought fund in October for the third consecutive month according to data from Interactive Investor.The star manager attracted more than double the amount of trades of the second most-bought fund, Money Observer Rated Fund
, which similarly retained its place for the third month in a row.Commenting on the results, Rebecca O'Keeffe, head of investment at Interactive Investor, says: "With income remaining a major priority for a large number of investors, the highly respected Neil Woodford remains an active choice for many.
"This is particularly the case in an environment which has seen a number of large income stocks cut their dividend yield in recent weeks. Although his fund only launched in June, the much-lauded manager has already proven his value, and is currently outperforming his peer group," she says.
Top performers
In the three months to 31 October CF Woodford UK Equity Income is the top-performing fund in the UK equity income sector, gaining 4.7%; however in the month to 31 October the fund lost 0.4%, placing it in the third quartile of the sector over the period.
In contrast, First State Asia Pacific Leaders enjoyed a strong month, returning 3.7% between the 30 September and 31 October helping to drive 12-month returns up to 12% and three-year returns up to 36.7%.
The third most-bought fund was fellow Money Observer Rated Fund
. Launched in 2001, the fund invests exclusively in the shares of global companies involved in the biotechnology, genomics and medical research industries.In the month to 31 October AXA Framlington Biotech returned a heady 9.5%, while over one year to 31 October it has returned 44% and nearly 200% in the three years to 31 October - making it the best-performing fund in the top 10 by a wide margin.
First State and AXA's funds were among only four funds in the top 10 to invest outside of the UK, with investors continuing to prefer domestic equities.
, one of Woodford's former funds, was the fourth most-bought fund again for the third consecutive month.Despite suffering heavy outflows as investors followed Woodford into his new fund, Invesco Perpetual High Income has returned 3.3% in the six months to 31 October and 9% in the 12 months to 31 October, placing it in the top quartile of the UK all companies sector over both periods.
Tracker fund popularity
The
was the fifth most-bought fund in October, retaining its place from September.The fund is a regular constituent of the top 10 most bought as is the
, which re-entered the table for the first time since March at number 10. Both funds are constituents of the growth-focused Money Observer Model Portfolios., the Money Observer Rated Fund managed by Terry Smith, was the sixth most-bought fund overall. At 60% of the portfolio the global fund is largely invested in US equities, which has helped to drive its performance in recent months.
Over the 12 months to 31 October the fund has returned 15%, making it the fourth best performer in the 258-strong global sector.
Joining the HSBC trackers were two Vanguard tracker funds:
and , which were the seventh and eighth most-bought funds respectively.This brought the total number of tracker funds in the top 10 up to four - the highest number to ever feature in most bought.
This perhaps reflects the rising popularity of tracker funds, which passively track equity or bond indices for fees typically much lower than those charged by actively managed funds.
Trackers attracted record breaking inflows in August when the Investment Management Association reported sales of £513 million.
O'Keeffe comments: "Tracker funds have been in sharp focus over the past few months, with a price war having broken out between a number of large fund groups.
"This is having a positive impact on overall passive investment levels, with tracker funds now representing over 10% of UK retail assets under management."
, another Money Observer Rated Fund, was the ninth most-bought fund for the second month in a row as it continues to regain ground following recent outflows prompted by the untimely death of the fund's former manager John McClure in June.
Rank | Fund | Sector | % return 1yr to 31 Oct | % return 3yr to 31 Oct |
1 | CF Woodford Equity Income | UK equity income | n/a | n/a |
2 | First State Asia Pacific Leaders | Asia Pacific ex Japan | 12 | 36.6 |
3 | AXA Framlington Biotech | Specialist | 43.7 | 198 |
4 | Invesco Perpetual High Income | UK all companies | 8.9 | 47.1 |
5 | HSBC FTSE 250 Index | UK all companies | 2.6 | 56.8 |
6 | Fundsmith Equity | Global | 15.0 | 63.7 |
7 | Vanguard LifeStrategy 80% Equities | Mixed investment 40-85% shares | 6.4 | 38.2 |
8 | Vangaurd FTSE UK Equity Index | UK all companies | 0.9 | 35.9 |
9 | Unicorn UK Income | UK equity income | -1.12 | 73.3 |
10 | HSBC FTSE All Share Index | UK all companies | 0.6 | 32.8 |
This article is for information and discussion purposes only and does not form a recommendation to invest or otherwise. The value of an investment may fall. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.